Skip to main content
VBIO
NASDAQ Life Sciences

Valion Bio Formulates Oral Mucosal Entolimod, Sees 10-40x Dose Opportunity

Tom Rudovsky · Reported by ACCESS Newswire
More coverage: Medical Device Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$3.33
Mkt Cap
$2.512M
52W Low
$2.05
52W High
$78.75
52W Position info
62% above low
Off High info
96% below high
Rel. Volume info
0.6× avg
Market data snapshot near publication time

VBIO sits 62% above its 52-week low of $2.05.

Summary

Valion Bio and Shear Kershman Laboratories successfully formulated an oral mucosal version of Entolimod using the BioViscid platform. This creates a second delivery pathway alongside the injectable program. The company estimates the oral formulation could address 10 to 40 times the number of doses compared to injectable Entolimod, targeting military, firefighters, and law enforcement. Next study will test systemic exposure. This follows a period of activist-driven management changes and financing challenges; the milestone offers a potential expansion of the company's addressable market.

At the time of this announcement, VBIO was trading at $3.33 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $2.5M. The 52-week trading range was $2.05 to $78.75. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: ACCESS Newswire.


Price Chart

Share this article

Copied!

VBIO - Latest Insights

VBIO
Nov 16, 2026, 4:12 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.510
Real-time Price: $0.5144 info
Change: +$0.0044 (+0.86%) info
Market Cap: $1.099M info
VBIO
Nov 05, 2026, 4:15 PM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $0.502
Real-time Price: $0.5144 info
Change: +$0.0124 (+2%) info
Market Cap: $1.099M info
VBIO
Nov 02, 2026, 7:50 AM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.585
Real-time Price: $0.5144 info
Change: -$0.0706 (-12%) info
Market Cap: $1.099M info
VBIO
Oct 30, 2026, 7:50 AM EDT
Source: ACCESS Newswire
Importance Score:
7
Price at Filing: $0.6373
Real-time Price: $0.5144 info
Change: -$0.1229 (-19%) info
Market Cap: $1.099M info
VBIO
Oct 29, 2026, 7:45 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.6758
Real-time Price: $0.5144 info
Change: -$0.1614 (-24%) info
Market Cap: $1.099M info